Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M3MTHRF 86 3-Year Dividend Growth Rate is 5.00% as of Mar. 2026, which is 74% below its 10-year median of 18.95. GuruFocus rates MTHRF with a GF Score™ of 86/100 and a GF Value™ of $17.44 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 166 Healthcare Providers & Services companies, M3 ranks worse than 63.86% on this metric.
The historical rank and industry rank for M3's 3-Year Dividend Growth Rate or its related term are showing as below:
MTHRF'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 5 Med: 18.95 Max: 31.7
Current: 5
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of M3 was 31.70% per year. The lowest was 5.00% per year. And the median was 18.95% per year.
MTHRF's 3-Year Dividend Growth Rate is ranked worse than 63.86% of 166
companies
in the Healthcare Providers & Services industry
Industry Median: 10.9
vs MTHRF: 5.00
During the past 12 months, M3's average Dividends Per Share Growth Rate was 4.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 11.90% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 20.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of M3 was 0.35. The lowest was 0.19. And the median was 0.25.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
M3 Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 22.000000
2026-03-30
2026-03-31
2026-06-12
Cash Dividend
semi-annually
JPY:USD 0.006286
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
M3's Dividend Yield (%) for Today is calculated as
Current Share Price is $10.3625.
M3's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.138292.
During the past 13 years, the highest Dividend Yield of M3 was 1.82%. The lowest was 0.08%. And the median was 0.34%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M3 3-Year Dividend Growth Rate Related Terms>
MTHRF vs VEEV, BTSG, TEM: 3-Year Dividend Growth Rate Comparison
For the Health Information Services subindustry, M3's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M3 3-Year Dividend Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, M3's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where M3's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 5.00% mean?
M3 (MTHRF) has a 3-Year Dividend Growth Rate of 5.00% as of Mar. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on M3 and its competitors. This is 74% below median its historical median of 18.95. Over the past decade, M3's 3-Year Dividend Growth Rate has ranged from 5.00 to 31.70. According to the industry distribution chart, M3 ranks #106 out of 166 companies in the Healthcare Providers & Services industry, placing it in the top 63.9%.
Is M3's 3-Year Dividend Growth Rate too high?
M3's current 3-Year Dividend Growth Rate of 5.00% is 74% below median its 10-year median of 18.95. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 31.70. The Healthcare Providers & Services industry median 3-Year Dividend Growth Rate is 10.90. M3's value of 5.00% is 54.1% below this industry median. Based on the distribution chart, M3 ranks #106 out of 166 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, M3 has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's 3-Year Dividend Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, M3 ranks #106 out of 166 companies for 3-Year Dividend Growth Rate. This places M3 in the lower half of its industry. The industry median 3-Year Dividend Growth Rate is 10.90. M3's value of 5.00% is 54.1% below this benchmark. Historically, M3's own 3-Year Dividend Growth Rate has ranged from 5.00 to 31.70 over the past decade. While the company's 10-year median is 18.95 vs. the industry median of 10.90, M3 has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Dividend Growth Rate among Healthcare Providers & Services companies is 10.90, based on 166 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M3's current 3-Year Dividend Growth Rate of 5.00% is 54.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on M3 and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Dividend Growth Rate is 10.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M3's current 3-Year Dividend Growth Rate is 5.00%, which is 74% below median its own 10-year median of 18.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (MTHRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.44, compared to a current price of $10.36 — trading 40.6% below its estimated fair value. The current 3-Year Dividend Growth Rate is 5.00%, which is 74% below median its 10-year median of 18.95 and 54.1% below the Healthcare Providers & Services industry median of 10.90. M3's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For M3 (MTHRF), the current 3-Year Dividend Growth Rate is 5.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M3 (MTHRF) Overvalued in 2026?
Based on GuruFocus' analysis, M3 stock appears to be undervalued.
The current stock price of $10.36 is trading 40.6% below its estimated GF Value™ of $17.44.
GuruFocus considers M3 to be Significantly Undervalued.
Key valuation signals for MTHRF:
3-Year Dividend Growth Rate: 5.00% (74% below median its 10-year median of 18.95)
GF Value™: $17.44 vs. price of $10.36 (40.6% below fair value)
Industry Position: 54.1% below the Healthcare Providers & Services median (#106 of 166)
No single metric tells the full story. See the MTHRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
86GF Score
Get the complete analysis for MTHRF
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MTHRF has been successfully added to your 
